Haematologic Technologies
Overview
Haematologic Technologies, Inc. (HTI) is a primary manufacturer that specializes in the isolation and characterization of high quality, plasma proteins which are intended for in vitro research use.
HTI’s emphasis is focused on proteins involved in the regulation of blood coagulation and fibrinolysis, as well as the regulation of bone metabolism.
The HTI product line consists of over 150 highly purified and well-characterized proteins including zymogens, enzymes, cofactors, and inhibitors as well as a complementary line of monoclonal and polyclonal antibodies. Additionally, HTI offers a broad line of services, which includes: custom protein purification, protein modification, assay development, contract manufacturing and contract research.
Website:
http://www.haemtech.com/Country of Origin:
USACoverage:
SingaporeProduct Range:
- Antibodies
- Assay Kits
- Bovine Proteins
- Deficient Plasmas
- Human Proteins
- Inhibitors
- Mouse Proteins
- Sample Collection Tubes
- Substrates
[E-mail Us]
Introductory Offer on 1st BASE Products!
10% Discount on 1st BASE's BIO- and BUF-series Products!
Promotion valid till 31 March 2012.
Click here for more information.